151 related articles for article (PubMed ID: 25288059)
21. Clinical characteristics and prognostic analysis of Chinese dermatomyositis patients with malignancies.
Shao C; Li S; Sun Y; Zhang Y; Xu K; Zhang X; Huang H
Medicine (Baltimore); 2020 Aug; 99(34):e21899. PubMed ID: 32846853
[TBL] [Abstract][Full Text] [Related]
22. Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center.
Klein RQ; Teal V; Taylor L; Troxel AB; Werth VP
J Am Acad Dermatol; 2007 Dec; 57(6):937-43. PubMed ID: 17923170
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis.
Fardet L; Dupuy A; Gain M; Kettaneh A; Chérin P; Bachelez H; Dubertret L; Lebbe C; Morel P; Rybojad M
Medicine (Baltimore); 2009 Mar; 88(2):91-97. PubMed ID: 19282699
[TBL] [Abstract][Full Text] [Related]
24. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111
[No Abstract] [Full Text] [Related]
25. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
So MW; Koo BS; Kim YG; Lee CK; Yoo B
J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
[TBL] [Abstract][Full Text] [Related]
26. Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort.
Neri R; Barsotti S; Iacopetti V; Iacopetti G; Pepe P; d'Ascanio A; Tavoni AG; Mosca M; Bombardieri S
Rheumatol Int; 2014 Apr; 34(4):565-9. PubMed ID: 24322453
[TBL] [Abstract][Full Text] [Related]
27. Juvenile Dermatomyositis in Afro-Caribbean children: a cohort study in the French West Indies.
Felix A; Delion F; Louis-Sidney F; Osei L; Armougon A; Bellance R; Dramé M; Deligny C; Suzon B; Hatchuel Y
Pediatr Rheumatol Online J; 2023 Oct; 21(1):113. PubMed ID: 37805487
[TBL] [Abstract][Full Text] [Related]
28. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.
Fukamatsu H; Hirai Y; Miyake T; Kaji T; Morizane S; Yokoyama E; Hamada T; Oono T; Koyama Y; Norikane S; Iwatsuki K
J Dermatol; 2019 Oct; 46(10):886-897. PubMed ID: 31418479
[TBL] [Abstract][Full Text] [Related]
29. Strong correlation between cancer progression and anti-transcription intermediary factor 1γ antibodies in dermatomyositis patients.
Ogawa-Momohara M; Muro Y; Mitsuma T; Katayama M; Yanaba K; Nara M; Kakeda M; Kono M; Akiyama M
Clin Exp Rheumatol; 2018; 36(6):990-995. PubMed ID: 29745874
[TBL] [Abstract][Full Text] [Related]
30. Incidence and predictive factors for malignancies with dermatomyositis: a cohort from southern China.
Chen D; Yuan S; Wu X; Li H; Qiu Q; Zhan Z; Ye Y; Lian F; Liang L; Xu H; Yang X
Clin Exp Rheumatol; 2014; 32(5):615-21. PubMed ID: 25068842
[TBL] [Abstract][Full Text] [Related]
31. Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study.
Cho SK; Kim H; Myung J; Nam E; Jung SY; Jang EJ; Yoo DH; Sung YK
J Korean Med Sci; 2019 Mar; 34(8):e55. PubMed ID: 30833879
[TBL] [Abstract][Full Text] [Related]
32. The epidemiology of dermatomyositis in northwestern Thrace region in Turkey: epidemiology of dermatomyositis in Turkey.
Balci MA; Donmez S; Saritas F; Bas V; Pamuk ON
Rheumatol Int; 2017 Sep; 37(9):1519-1525. PubMed ID: 28386737
[TBL] [Abstract][Full Text] [Related]
33. Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis.
Hanissian AS; Masi AT; Pitner SE; Cape CC; Medsger TA
J Rheumatol; 1982; 9(3):390-4. PubMed ID: 7120234
[TBL] [Abstract][Full Text] [Related]
34. [Epidemioclinical aspects of dermatomyositis in the region of Tunis].
Khelifa E; Benmously R; Fenniche S; Marrak H; Zghal M; Mokhtar I
Tunis Med; 2007 Aug; 85(8):655-8. PubMed ID: 18254286
[TBL] [Abstract][Full Text] [Related]
35. Dermatomyositis sine myositis: association with malignancy.
Whitmore SE; Watson R; Rosenshein NB; Provost TT
J Rheumatol; 1996 Jan; 23(1):101-5. PubMed ID: 8838516
[TBL] [Abstract][Full Text] [Related]
36. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.
Fiorentino DF; Chung LS; Christopher-Stine L; Zaba L; Li S; Mammen AL; Rosen A; Casciola-Rosen L
Arthritis Rheum; 2013 Nov; 65(11):2954-62. PubMed ID: 24037894
[TBL] [Abstract][Full Text] [Related]
37. Association of antinuclear antibody status with clinical features and malignancy risk in adult-onset dermatomyositis.
Hoesly PM; Sluzevich JC; Jambusaria-Pahlajani A; Lesser ER; Heckman MG; Abril A
J Am Acad Dermatol; 2019 May; 80(5):1364-1370. PubMed ID: 30458207
[TBL] [Abstract][Full Text] [Related]
38. Clinical and laboratory characteristics of idiopathic inflammatory myositis in Saudi patients: A retrospective study in a single tertiary centre.
Alenzi F; Alotaibi J; Alnasser M; Alokaily F
Saudi Med J; 2023 May; 44(5):492-497. PubMed ID: 37182927
[TBL] [Abstract][Full Text] [Related]
39. Low prevalence of malignancy in patients with idiopathic inflammatory myopathies in Jordan.
Mustafa KN; Al-Heresh AM; Khataybeh OY; Alawneh KM; Khader YS
Clin Exp Rheumatol; 2015; 33(5):731-3. PubMed ID: 26344556
[TBL] [Abstract][Full Text] [Related]
40. Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan.
Hsu JL; Liao MF; Chu CC; Kuo HC; Lyu RK; Chang HS; Chen CM; Wu YR; Chang KH; Weng YC; Chang CW; Chiang HI; Cheng CK; Lee PW; Huang CC; Ro LS
Sci Rep; 2021 Feb; 11(1):4545. PubMed ID: 33633147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
